Treatment of Idiopathic Pulmonary Fibrosis with Long Acting Octreotide

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2012

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

octreotide

Trial Locations (16)

13274

Service de Pneumologie Hôpital Sainte Marguerite BP 29, Marseille

14000

Service de Pneumologie Hôpital Côte de Nacre, Caen

35000

Service de Pneumologie Hôpital Pontchaillou, Rennes

59037

Service de Pneumologie Hôpital Albert calmette, Lille

75012

Service de Pneumologie Hôpital Saint-Antoine, Paris

75018

Hôpital Bichat 46 rue Henri Huchard, Paris

Service de Pneumologie A Hôpital Bichat 1, Paris

75475

Service de Pneumologie Hôpital Saint Louis 1 avenue Claude-Vellefaux, Paris

75651

Service de Pneumologie Hôpital de la Pitié-Salpetrière 47-83 boulevard de l'hôpital, Paris

75679

Service de Pneumologie Hôpital Cochin, Paris

75908

Service de Pneumologie Hôpital Georges Pompidou, Paris

75970

Service de Pneumologie A Hôpital Tenon, Paris

92100

Service de Pneumologie Hôpital Ambroise Paré, Boulogne-Billancourt

92140

Service de Pneumologie Hôpital Antoine Béclère, Clamart

93009

Service de Pneumologie Hôpital Avicenne 125 rue de Stalingrad, Bobigny

94010

Service de Pneumologie Centre hospitalier intercommunal de Créteil, Créteil

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT00463983 - Treatment of Idiopathic Pulmonary Fibrosis with Long Acting Octreotide | Biotech Hunter | Biotech Hunter